2023 CiteScore: 0.8
pISSN: 2345-5829
eISSN: 2345-5837
Editor-in-Chief:
Mohammad Reza Ay
Chairman:
Saeid Sarkar
Executive Director:
Hossein Ghadiri
The Journal of "Frontiers in Biomedical Technologies" is a peer-reviewed, multidisciplinary journal. It is a medium for researchers, engineers, scientists and other professionals in biomedical technologies to record publish and share ideas and research findings that serve to enhance the understanding of medical imaging methods and systems, Nano imaging and nanotechnology, surgical navigation, medical robotics, biomechanical and bioelectrical systems, stem cell technology, etc.
As we step into 2023, the landscape of translational medicine continues to evolve, revealing the profound importance of preclinical imaging in bridging the gap between laboratory discoveries and clinical applications. Preclinical imaging allows researchers to visualize biological processes in real time, providing invaluable insights into the efficacy and safety of new therapeutic strategies.
The ability to monitor changes at the organ, tissue, cellular, and molecular levels is not just a technological feat; it is a cornerstone of modern biomedical research. Non-invasive imaging techniques, such as high-frequency micro-ultrasound, MRI, CT, and advanced molecular imaging modalities like PET and SPECT, empower scientists to track disease progression and treatment responses longitudinally. This capability is particularly crucial in translational medicine, where understanding the dynamics of disease and therapy can lead to more effective interventions.
At the forefront of this innovation is the TPCF (Tehran University of Medical Science Preclinical Core Facility), which champions the integration of science and technology in preclinical imaging. The 6th International TPCF Preclinical Imaging Symposium (TPIS 2023) promised to be a pivotal event for researchers dedicated to enhancing translational research. With an impressive lineup of keynote speakers and workshops, the symposium delved into cutting-edge imaging technologies that are revolutionizing drug discovery and development.
The significance of preclinical imaging cannot be overstated; it not only accelerates the translation of research findings into clinical settings but also fosters collaboration among scientists, engineers, and clinicians. By sharing knowledge and resources, we can collectively push the boundaries of what is possible in medical science.
We are excited that Frontiers in Biomedical Technology (FBT) will once again publish the abstracts from the TPIS 2023, ensuring that groundbreaking research reaches a wider audience. We invite all interested researchers and professionals to join us at TPIS 2024 for an enriching experience that promises to inspire new ideas and partnerships.
For more information about the symposium and registration details, please visit our website at www.TPCF.ir. Together, let us continue to illuminate the path from bench to bedside through the transformative power of preclinical imaging.
2023 CiteScore: 0.8
pISSN: 2345-5829
eISSN: 2345-5837
Editor-in-Chief:
Mohammad Reza Ay
Chairman:
Saeid Sarkar
Executive Director:
Hossein Ghadiri
All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source. |